Results 251 to 260 of about 1,610,894 (277)
Some of the next articles are maybe not open access.

Abstract LB-B15: A novel PI3K gamma isoform selective small molecule kinase inhibitor demonstrates single agent anti-tumor activity and enhanced combination activity with checkpoint blockade in syngeneic mouse models of cancer

Molecular Cancer Therapeutics, 2015
Abstract Immune checkpoint inhibitors have generated impressive clinical responses, however, a number of patients and cancer types remain resistant to checkpoint blockade. Immunosuppressive cells such as Tregs and MDSCs in the tumor microenvironment are hypothesized to mediate this resistance.
Saurabh Saha   +15 more
openaire   +1 more source

Abstract 532: Irradiation alters the tumor microenvironment of orthotropic pancreatic tumor in favoring the infiltration of PD1+CD8 and G-MDSC and the delivery of immune checkpoint blockade therapy agents

Cancer Research, 2019
Abstract Immunotherapy (IT) is trending on cancer research, but its efficacy heavily depends on the tumor microenvironment (TME). IT is also frequently combined with radiation therapy (RT). Here, we explored the effect of radiation therapy (RT) on the TME and its consequence on the combination of IT using a syngeneic orthotropic UN ...
openaire   +1 more source

1352 Selective small molecule Inhibitor of integrin αVβ8 and αVβ1 has single agent activity and potentiates immune checkpoint blockade therapy

Regular and Young Investigator Award Abstracts, 2022
Vishal Kothari   +17 more
openaire   +1 more source

EGFR Mutation Subtypes and Response to Immune Checkpoint Blockade Treatment in Non-Small-Cell Lung Cancer

Annals of Oncology, 2019
Matthew D Hellmann   +2 more
exaly  

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Cell, 2017
Alexandria P. Cogdill   +2 more
exaly  

Home - About - Disclaimer - Privacy